Lincoln Pharma launches Ondansetron oral spray in India

NEW DELHI: Lincoln Pharmaceuticals has launched Ondansetron oral spray, used for treatment of nausea and vomiting caused by surgery or cancer drugs, in the Indian market.

Ondansetron was earlier available as tablet, syrup and injectable in India, Lincoln Pharma said in a filing to BSE.

The company has "done bio-equivalent study for Ondansetron oral spray and has got the Drug Controller General of India (DCGI) permission," it added.

The product has been launched in the Indian market in two strengths, Lincoln Pharm said.

Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery.

Shares of Lincoln Pharma were today trading at Rs 240 per scrip in the afternoon trade on BSE, up 3.38 per cent from its previous close.